Drug manufacturer Allergan reached a $2.37 billion settlement with a bipartisan group of state attorneys general to resolve lawsuits over the opioid crisis.

The deal, announced by attorneys general in eight states, including California and Illinois, comes five days after another opioid manufacturer, Teva Pharmaceutical Industries Ltd., reached a $4.25 billion deal to resolve thousands of lawsuits. Teva, which bought Allergan’s generics portfolio in 2016, said its settlement was contingent on Allergan reaching a similar deal.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]